Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Pharvaris BV stock

Learn how to easily invest in Pharvaris BV stock.

Pharvaris BV is a biotechnology business based in the US. Pharvaris BV shares (PHVS) are listed on the NASDAQ and all prices are listed in US Dollars. Pharvaris BV employs 56 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Pharvaris BV stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – PHVS. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.

Pharvaris BV stock price (NASDAQ: PHVS)

Use our graph to track the performance of PHVS stocks over time.

Pharvaris BV shares at a glance

Information last updated 2023-01-25.
Latest market close$9.10
52-week range$1.77 - $27.50
50-day moving average $7.04
200-day moving average $12.84
Wall St. target price$17.42
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.52

Buy Pharvaris BV stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Pharvaris BV stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pharvaris BV price performance over time

Historical closes compared with the close of $9.1 from 2023-01-30

1 week (2023-01-24) -9.99%
1 month (2022-12-30) -19.11%
3 months (2022-11-01) 116.67%
6 months (2022-08-01) -54.50%
1 year (2022-02-01) -46.47%
2 years (2021-01-28) N/A
3 years (2020-01-28) N/A
5 years (2018-01-28) N/A

Pharvaris BV financials

Gross profit TTM $0
Return on assets TTM -23.91%
Return on equity TTM -25.37%
Profit margin 0%
Book value $5.48
Market capitalisation $324.7 million

TTM: trailing 12 months

Pharvaris BV share dividends

We're not expecting Pharvaris BV to pay a dividend over the next 12 months.

Pharvaris BV overview

Pharvaris N. V. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients and is under Phase 1 clinical trial. It operates in the Netherlands, Switzerland, and the United States. The company was incorporated in 2015 and is based in Leiden, the Netherlands.

Frequently asked questions

What percentage of Pharvaris BV is owned by insiders or institutions?
Currently 9.626% of Pharvaris BV shares are held by insiders and 76.853% by institutions.
How many people work for Pharvaris BV?
Latest data suggests 56 work at Pharvaris BV.
When does the fiscal year end for Pharvaris BV?
Pharvaris BV's fiscal year ends in December.
Where is Pharvaris BV based?
Pharvaris BV's address is: J.H. Oortweg 21, Leiden, Netherlands, 2333 CH
What is Pharvaris BV's ISIN number?
Pharvaris BV's international securities identification number is: NL00150005Y4

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site